Delivery Order SPE2DB22D2006-SPE2DB25FV8EU
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Azithromycin 250 mg tablets, a common antibiotic medication, with a ceiling value of $3,769.66 and a period of performance through June 4, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any special program. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Azithromycin 250 mg tablet 6s, a common antibiotic medication, with a ceiling value of $1,265.46 and a completion date of July 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a significant...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.23, is for the delivery of azithromycin 250mg tablets. The contract has a period of performance through February 19, 2025 and is a Firm Fixed Price contract type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,942.16 firm fixed-price delivery order is for 4,564,983,997 units of the generic drug Azithromycin 500 mg tablets, with a performance period through May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for Azithromycin 250 mg tablets in quantities of 30 units. This is a firm fixed-price contract with a ceiling value of $2,476.68 and an ultimate completion date of September 19, 2025. The award represents a non-competitive, non-set-aside transaction executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $13,418.30 and an ultimate completion date of January 21, 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. and serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of Azithromycin 250 mg tablets, a pharmaceutical product, at a ceiling value of $1,132.92. The contract has a completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is valued at up to $999,999,999...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,452,985 units of Azithromycin 250 mg tablets. The $7,048.79 contract has a completion date of January 29, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds a single-award indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,165.05, is for the delivery of 4567317010 - Azithromycin 500 mg Tablet 30s. It is a firm fixed-price delivery order contract with a completion date of February 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a $2,604.70 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FV8EUDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of 4,567,198,344 units of Azithromycin 250 mg tablets, a pharmaceutical product used to treat various bacterial infections. The contract has a ceiling value of $2,371.38 and a completion date of February 7, 2025. This appears to be a delivery order contract, with a firm fixed price pricing type. The contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/6/25 |